Back

Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals

27 August 2022 (08:15 - 09:00)
Organised by:
Congress Presentation Part of: Cardiovascular risk assessment and scores Scores ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ali Yari

Karolinska Institute, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP
Doctor S. Hageman (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility - a coronary calcium score correlation study
Miss M. Paiva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Associations of SCORE2, circulating cardiovascular biomarkers and carotid intima-media-thickness in a population-based cohort
Doctor B. Toprak (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Comparison between the European SCORE and the updated SCORE2 for cardiovascular outcomes
Doctor M. Temtem (Funchal, PT)
Abstract Slides
Presentation thumbnail
In a large dataset of primary care patients, use of CHA2DS2-VA score leads to almost universal recommendation for anticoagulation in those aged 65 years and over with atrial fibrillation
Doctor J. Orchard (Sydney, AU)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk assessment and scores

The Event

Event poster

ESC Congress 2022

27 August 2022 08:15 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
thumbnail
Practice Tools
Risk Scores in Secondary Cardiovascular Prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources